Hunan Huichuntang Pharmaceutical Co., Ltd., commonly referred to as Huichuntang, is a prominent player in the pharmaceutical industry, headquartered in Changsha, Hunan Province, China. Established in 1993, the company has made significant strides in the development and production of traditional Chinese medicine, herbal extracts, and health supplements, catering to both domestic and international markets. With a commitment to quality and innovation, Huichuntang offers a diverse range of products that stand out for their efficacy and adherence to traditional practices. The company has achieved notable recognition for its contributions to the field, positioning itself as a leader in the integration of modern technology with ancient medicinal wisdom. Through its extensive research and development efforts, Huichuntang continues to enhance its market presence, solidifying its reputation as a trusted name in health and wellness solutions.
How does Hunan Huichuntang Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hunan Huichuntang Pharmaceutical Co., Ltd.'s score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hunan Huichuntang Pharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate action. However, without specific data or commitments from Hunan Huichuntang Pharmaceutical, it is challenging to assess their position relative to industry standards or peers. The absence of emissions data and reduction initiatives highlights an opportunity for the company to enhance its environmental strategy and align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hunan Huichuntang Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
